Vitamin A Supplementation Guidelines for Pediatric Populations

Prophylactic Supplementation by Age

• Infants younger than 6 months should receive 100,000 IU of vitamin A orally every 3 months when a reliable schedule can be maintained; if not, an alternative regimen of 200,000 IU every 6 months or a single 200,000 IU dose may be used, providing a total of approximately 400,000 IU in the first year. 1
• Infants 6–12 months receive 100,000 IU orally every 3 months in high‑risk settings, continuing through the first year of life. 1
• Children 12 months to <5 years receive 200,000 IU orally every 3 months (or every 3–6 months) until the age of 5 years. 1
• Post‑partum mothers of breast‑fed infants should be given a single 200,000 IU dose within 2 months after delivery to enrich breast‑milk vitamin A content. 1

Treatment of Clinical Vitamin A Deficiency (Xerophthalmia)

• Standard emergency regimen for children of any age: 200,000 IU orally on day 1, another 200,000 IU on day 2, and a third 200,000 IU dose administered once between weeks 1–4. 1
• Infants younger than 12 months receive half‑strength doses (100,000 IU) on day 1, day 2, and at 1–4 weeks. 1
• Indications for treatment include clinical signs of xerophthalmia (night blindness, conjunctival xerosis, Bitot’s spots), corneal involvement (xerosis, ulceration, keratomalacia), and severe malnutrition defined by a markedly low weight‑for‑height measurement. 1

Parenteral Nutrition Dosing for Hospitalised Children

All parenteral doses should be delivered with a lipid emulsion to prevent substantial drug loss. 2

Risk‑Based Indications for Prophylactic Supplementation

• Provide prophylactic vitamin A when any of the following are present: (1) the child originates from a geographic area with a high prevalence of vitamin A deficiency, (2) there is documented severe deficiency in the community, or (3) the typical dietary intake is estimated to be less than 2,000–2,500 IU per person per day. 1

Monitoring, Documentation, and Safety

• Documentation: Record every vitamin A dose on the child’s growth‑chart record; repeat serum retinol measurement 3 months after a therapeutic course. 1
• Toxicity awareness: The therapeutic window is narrow; acute toxicity can present with increased intracranial pressure, headache, nausea, vomiting, vertigo, and blurred vision, while chronic excess may cause bone abnormalities, dermatitis, alopecia, ataxia, and muscle pain. 3
• Pregnancy precaution: Retinol is teratogenic; women of child‑bearing potential should limit intake to <10,000 IU / day. 3

Practical Pitfalls to Avoid

• Do not use water‑based solutions for parenteral vitamin A—use lipid emulsions exclusively. 2
• Do not under‑dose infants <12 months with clinical deficiency; they require exactly half the standard treatment dose (100,000 IU), not a lower amount. 1
• Keep clear separation between prophylactic (100,000–200,000 IU every 3 months) and therapeutic (200,000 IU on consecutive days) regimens to prevent dosing errors. 1

Strength of evidence: Recommendations are derived from CDC MMWR (1992) and peer‑reviewed nutrition literature (Clinical Nutrition 2016, 2018); specific grading levels were not provided in the source documents.

Vitamin A Repletion Dosing Regimen

Age-Specific Dosing for Vitamin A Deficiency

• The American College of Cardiology is not mentioned, however, the Obesity Reviews recommends treating vitamin A deficiency with 10,000-25,000 IU oral vitamin A daily for 1-2 weeks for clinical improvement in adults 4, 5
• Recheck vitamin A levels at 3 months after treatment in adults 4
• For vitamin A deficiency that does not respond to oral treatment, refer to a specialist for assessment and consideration of intramuscular vitamin A injections 4

Children with Clinical Vitamin A Deficiency (Xerophthalmia)

• The Centers for Disease Control and Prevention, as per MMWR Recommendations and Reports, recommends the following treatment schedule for children with eye symptoms of vitamin A deficiency:

Preventive Supplementation in High-Risk Populations

• The World Health Organization, as per MMWR Recommendations and Reports, recommends the following preventive supplementation:

Monitoring and Follow-Up

• Document all doses of vitamin A on the child's growth record chart 6
• Recheck vitamin A levels 3 months after treatment in adults 4
• Monitor for clinical improvement in night vision and other symptoms of deficiency 4, 5

Special Considerations

• Vitamin A toxicity is rare but possible, particularly with prolonged high doses, as per Clinical Nutrition 7
• Acute toxicity (>150,000 μg) can present with increased intracranial pressure (headache, nausea/vomiting, vertigo, blurred vision) 7
• Chronic toxicity (approximately 30,000 μg/day) can present with bone abnormalities, dermatitis, alopecia, and other symptoms 7
• For adolescents with vitamin A deficiency, specialist referral is recommended 4

Treatment Resistance

• For vitamin A deficiency that does not respond to standard oral treatment, refer to specialists for assessment and consideration of intramuscular vitamin A injections 4, 5
• Consider investigating for underlying malabsorption or other causes of persistent deficiency 4